Lensar (LNSR) Assets Growth (1y) (2020 - 2026)
Lensar (LNSR) Assets Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Lensar | 65.49 Mn | 54.39 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.23% |
| Dec 31, 2025 | 7.74% |
| Sep 30, 2025 | 13.20% |
| Jun 30, 2025 | 14.67% |
| Mar 31, 2025 | 10.32% |
| Dec 31, 2024 | -4.73% |
| Sep 30, 2024 | -12.47% |
| Jun 30, 2024 | -13.75% |
| Mar 31, 2024 | 27.28% |
| Dec 31, 2023 | 24.61% |
| Sep 30, 2023 | 29.29% |
| Jun 30, 2023 | 21.29% |
| Mar 31, 2023 | -13.83% |
| Dec 31, 2022 | -15.98% |
| Sep 30, 2022 | -19.53% |
| Jun 30, 2022 | -19.02% |
| Mar 31, 2022 | -18.01% |
| Dec 31, 2021 | -15.99% |
| Sep 30, 2021 | -15.62% |
| Dec 31, 2020 | 129.09% |